-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IE/GSrn5ItE1KeFbiWIxOn2g1NwJl6/qGOo7XGCpVbMPbbmxEPzGpRUFUjnBTT5S jUK2LTC4UXLYm7/m+R02Kg== 0001299933-08-003547.txt : 20080722 0001299933-08-003547.hdr.sgml : 20080722 20080722161656 ACCESSION NUMBER: 0001299933-08-003547 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20080722 ITEM INFORMATION: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20080722 DATE AS OF CHANGE: 20080722 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MERCK & CO INC CENTRAL INDEX KEY: 0000064978 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221109110 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-03305 FILM NUMBER: 08963622 BUSINESS ADDRESS: STREET 1: ONE MERCK DR STREET 2: P O BOX 100 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 BUSINESS PHONE: 9084231688 MAIL ADDRESS: STREET 1: ONE MERCK DR STREET 2: PO BOX 100 WS3AB-05 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 8-K 1 htm_28189.htm LIVE FILING Merck & Co., Inc. (Form: 8-K)  

 


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     
Date of Report (Date of Earliest Event Reported):   July 22, 2008

Merck & Co., Inc.
__________________________________________
(Exact name of registrant as specified in its charter)

     
New Jersey 1-3305 22-1109110
_____________________
(State or other jurisdiction
_____________
(Commission
______________
(I.R.S. Employer
of incorporation) File Number) Identification No.)
      
One Merck Drive, P.O. Box 100, Whitehouse Station, New Jersey   08889
_________________________________
(Address of principal executive offices)
  ___________
(Zip Code)
     
Registrant’s telephone number, including area code:   908-423-1000

Not Applicable
______________________________________________
Former name or former address, if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(d) Incorporated by reference is a press release issued by Merck & Co., Inc. (the "Company") on July 15, 2008, attached as Exhibit 99.1, announcing the election of Leslie A. Brun to the Company's Board of Directors, effective July 22, 2008. The Board of Directors also appointed Mr. Brun, as a member of the Audit Committee of the Board.





Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit 99.1 Press Release issued July 15, 2008






SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Merck & Co., Inc.
          
July 22, 2008   By:   /s/ Debra A. Bollwage
       
        Name: Debra A. Bollwage
        Title: Senior Assistant Secretary


Exhibit Index


     
Exhibit No.   Description

 
99.1
  Press release issued July 15, 2008
EX-99.1 2 exhibit1.htm EX-99.1 EX-99.1

Exhibit 99.1

             
MERCK LOGO
          News Release
Media Contact:
  Amy Rose
(908) 423-6537
  Investor Contact:   Eva Boratto
(908) 423-5185

Leslie A. “Les” Brun Elected to Merck Board of Directors

WHITEHOUSE STATION, N.J., July 15, 2008 – Merck & Co., Inc. today announced that Leslie A. “Les” Brun, 55, chairman and chief executive officer of SARR Group, LLC, a diversified investment holding company, will join the Company’s board of directors effective July 22. With his election, Mr. Brun will become one of 13 independent directors on the board. The addition expands the Merck board to 14 members. Mr. Brun will stand for election by the Company’s stockholders in April 2009.

“Les brings a broad range of business and financial experience and we look forward to working with him on the board,” said Richard T. Clark, chairman, president and chief executive officer of Merck.

In 1991, Mr. Brun founded Hamilton Lane Advisors Inc., an independent investment management company. Prior to that role, he was a managing director at Fidelity Bank in Philadelphia where he founded the investment banking group.

Mr. Brun is currently the non-executive chairman of the board of directors of Automatic Data Processing, Inc. (ADP), a role he has held since 2007. He has been a member of ADP’s board since 2003, and he previously served as chair of the company’s Nominating and Corporate Governance Committee. Mr. Brun also serves on the boards of Philadelphia Media Holdings, LLC and Broadridge Financial Solutions, Inc.

Mr. Brun is a member of the Council on Foreign Relations, a trustee of the University at Buffalo Foundation, Inc, and a trustee of The Episcopal Academy in Philadelphia. He also served as chairman of the U. S. Small Business Administration’s S.B.I.C. Advisory Council and as a member of the Committee for the Reinvention of the S.B.A.

Mr. Brun earned a bachelor’s degree from The State University of New York at Buffalo.

About Merck

Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck currently discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The Company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service. For more information, visit www.merck.com.

# # #

-----END PRIVACY-ENHANCED MESSAGE-----